Welcome, Guest. Please login or register.
November 08, 2024, 06:11:16 pm

Login with username, password and session length


Members
Stats
  • Total Posts: 775154
  • Total Topics: 66568
  • Online Today: 1275
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 0
Guests: 1095
Total: 1095

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Trump removes protections of HIV drugs a day before leaving office.  (Read 8200 times)

0 Members and 1 Guest are viewing this topic.

Offline Almost2late

  • Member
  • Posts: 1,447
I remember reading a story in Poz.com about the asshole deciding not to do this a couple of years ago.. https://www.poz.com/article/drugs-medicare-plans-protected-classes-remain-protected#search-query=Medicare%20part%20d%20hiv%20trump

But according to this article.. https://www.washingtonblade.com/2021/02/19/trumps-final-blow-to-patients-with-hiv/ the spiteful little bitch decided to do it anyways..

Quote
"Trump’s final blow to patients with HIV"

The day before Donald Trump left the White House, his administration dealt one final, brutal blow to some of America’s most vulnerable patients. The Centers for Medicare and Medicaid Services announced a policy that, if implemented, will put numerous lifesaving drugs off-limits to Medicare recipients.

Medicare provides health insurance to 63 million seniors and people with disabilities. Trump’s gut punch affects Part D, the section of Medicare that covers most prescription drugs. The last-minute policy change would allow the private insurance companies that sponsor Part D plans to stop covering many medications in Part D’s “six protected classes” as early as 2022.

The protected classes include anticonvulsants, antidepressants, antineoplastics, antipsychotics, antiretrovirals, and immunosuppressants — drugs that treat conditions including epilepsy, depression, cancer, and HIV. The protected categories exist because these types of drugs are not easily interchangeable. An antipsychotic that treats one person’s schizophrenia, for instance, may be ineffective in another patient. Patients often have to try multiple treatments until they find one that works well for them.

Today under Part D, insurers must cover “all or substantially all” of the drugs that fall into those six classes. But under the proposed new policy, insurers would only have to cover one drug per class, starting next year. The policy makes one exception, for antiretrovirals to treat HIV, which would remain protected until 2023.

I live with HIV and depression, conditions I manage with drugs in the protected classes. So I know from personal experience that there is no one-size-fits-all pharmaceutical solution to my health challenges. It can be hard enough to find a prescription that helps treat one condition, and having two conditions means I have to find medications that work together effectively.

More than 47 million Americans depend on Part D plans, and many of them need medicines from the protected classes. If the new policy goes into effect, doctors and patients will lose options, and some will even find themselves suddenly cut off from trusted treatments. It’s a cruel thing to do to sick people.

Thankfully, I’m able to manage my HIV with medication. But the consequences of stopping treatment could be deadly for me, as it could for any of the estimated 1.2 million Americans living with the virus. This is a population, moreover, that is disproportionately Black. Whereas Blacks make up 13.4 percent of the U.S. population, they account for 42 percent of new HIV cases.

President Biden has promised to make healthcare “a right for all, not a privilege for just a few,” vowing to prioritize health care for people of color. He can do that by scrapping this callous policy.

The former administration’s reforms admittedly weren’t all bad. Last year, the Department of Health and Human Services proposed closing a legal loophole that allows middlemen in the drug supply chain to pocket rebates offered by biotech companies without passing those savings on to patients at the pharmacy. Allowing this “rebate rule” to take effect would make drugs more affordable.

But aside from scattered exceptions like the rebate rule, the Trump administration’s policies need to be reversed. The Biden administration can start with the disastrous, last-minute proposal to sabotage the six protected classes.



 


Terms of Membership for these forums
 

© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.